alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 176
Editorial Note: Nomenclature changes to part 176 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; and 70 FR 72074, Dec. 1, 2005.

§ 176.320 Sodium nitrate-urea complex. Sodium nitrate-urea complex may be safely used as a component of articles intended for use in producing, manufacturing, packing, processing, preparing, treating, packaging, transporting, or holding food, subject to the provisions of this section. ( a ) Sodium nitrate-urea complex is a clathrate of approximately two parts urea and one part sodium nitrate.
( b ) Sodium nitrate-urea complex conforming to the limitations prescribed in paragraph (b)(1) of this section is used as provided in paragraph (b)(2) of this section. ( 1 ) *Limitations.* ( i ) It is used as a plasticizer in glassine and greaseproof paper.
( ii ) The amount used does not exceed that required to accomplish its intended technical effect or exceed 15 percent by weight of the finished paper.
( 2 ) *Conditions of use.* The glassine and greaseproof papers are used for packaging dry food or as the food-contact surface for dry food.
#### CAROLYN FAULKS AND EDWARD A. FAULKS, PROSECUTORS, v. BOROUGH OF ALLENHURST, A MUNICIPAL CORPORATION OF THE STATE OF NEW JERSEY, RESPONDENT.

Argued January 37, 1939

Decided March 2, 1939.

Before Justices Case, Donges and Porter.

For the prosecutors, *Lindabury, Depue & Faulks (Lester C. Leonard,,*of counsel).

For the respondent, *Richard W. Stout (William J. O’Hagan,*of counsel).

The opinion of the court was delivered by

Porter, J.

The prosecutors seek a writ of *certiorari*to review an ordinance of the respondent providing for the installation of an outfall pipe extending into the ocean for disposing of sewage by order of the State Department of Health.

It appears that other litigation has resulted between the parties concerning sewage disposal resulting in a judgment of ouster in favor of the prosecutors against the respondent in a suit in ejectment relating to a chlorinator plant which affected property rights of prosecutors. *Faulks*v. *Allenhurst,*115 *N. J. L.*456.

*226The respondent has instituted proceedings under the Eminent Domain statute to acquire for public uses whatever rights the prosecutors had in the premises. Those proceedings are now pending and, we are informed, are nearing completion.

Meanwhile occurred the necessity for the building of the proposed outfall pipe at or near the site of the property of prosecutors, whereon is situated the said chlorinator plant, under the order of the State Department of Health and the adoption of the resolution under attack to effectuate that purpose.

It seems to us that the respondent was under an imperative duty to safeguard the public health by constructing this outfall pipe.

Under the circumstances and the evidence before us, we conclude that the action of the respondent in the adoption of the ordinance has not been shown to have been improper or to have infringed any rights of prosecutors, but on the contrary was well within the sound discretion of the respondent.

The application for the writ is denied, with costs.
<PAGE>

EXHIBIT 32 (B)

      CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT
                TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Northland Cable Properties Seven
Limited Partnership (the "Partnership") on Form 10Q for the period ended
September 30, 2006 as filed with the Securities and Exchange Commission on the
date hereof (the "Form 10-Q"), I, Gary Jones, President of Northland
Communications Corporation, the General Partner, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that;

          (1)  The Form 10-Q fully complies with the requirements of Section 13
               (a) or (15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
               78m or 78(d)); and

          (2)  The information contained in the Form 10-Q fairly presents in all
               material respects, the financial condition and results of
               operations of the Partnership.

DATE: 11-14-06


/s/ GARY S. JONES
-------------------------------------
Gary S. Jones
President

A signed original of this written statement required by Section 906 has been
provided to Northland Cable Properties Seven Limited Partnership and will be
retained by Northland Cable Properties Seven Limited Partnership and furnished
to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-26-1997
<PERIOD-START>                             DEC-28-1996
<PERIOD-END>                               MAR-29-1997
<CASH>                                          19,349
<SECURITIES>                                     6,226
<RECEIVABLES>                                   60,896
<ALLOWANCES>                                     1,745
<INVENTORY>                                     56,925
<CURRENT-ASSETS>                               165,779
<PP&E>                                         116,750
<DEPRECIATION>                                  55,045
<TOTAL-ASSETS>                                 247,691
<CURRENT-LIABILITIES>                           45,190
<BONDS>                                         13,313
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           113
<OTHER-SE>                                     185,147
<TOTAL-LIABILITY-AND-EQUITY>                   247,691
<SALES>                                         63,020
<TOTAL-REVENUES>                                63,020
<CGS>                                           31,489
<TOTAL-COSTS>                                   31,489
<OTHER-EXPENSES>                                32,866
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (1,335)
<INCOME-TAX>                                     1,934
<INCOME-CONTINUING>                            (3,269)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,269)
<EPS-PRIMARY>                                   (0.34)
<EPS-DILUTED>                                   (0.34)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<CIK> 0000945532
<NAME> USABANCSHARES, INC.
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               JUN-30-1996
<CASH>                                         192,175
<INT-BEARING-DEPOSITS>                       2,452,972
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                  3,065,194
<INVESTMENTS-CARRYING>                       8,431,696
<INVESTMENTS-MARKET>                         8,355,692
<LOANS>                                     11,758,832
<ALLOWANCE>                                    135,000
<TOTAL-ASSETS>                              26,442,047
<DEPOSITS>                                  21,537,217
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                            135,358
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       597,082
<OTHER-SE>                                   4,172,390
<TOTAL-LIABILITIES-AND-EQUITY>              26,442,047
<INTEREST-LOAN>                                832,595
<INTEREST-INVEST>                              351,400
<INTEREST-OTHER>                               144,417
<INTEREST-TOTAL>                             1,328,412
<INTEREST-DEPOSIT>                             553,893
<INTEREST-EXPENSE>                                   0
<INTEREST-INCOME-NET>                          774,519
<LOAN-LOSSES>                                   75,000
<SECURITIES-GAINS>                              22,063
<EXPENSE-OTHER>                                699,938
<INCOME-PRETAX>                                 67,259
<INCOME-PRE-EXTRAORDINARY>                      67,259
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                     0.08
<EPS-DILUTED>                                     0.08
<YIELD-ACTUAL>                                   10.55
<LOANS-NON>                                    344,000
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                60,000
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                              135,000
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                        135,000

</TABLE>
I 

118TH CONGRESS 

2D SESSION H. R. 7156 

To expand the investigative authorities of the United States Secret Service, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 31, 2024 

Mr. FITZGERALD (for himself, Mr. MEEKS, Mr. NUNN of Iowa, and Ms. DEAN

of Pennsylvania) introduced the following bill; which was referred to the 

Committee on Financial Services, and in addition to the Committee on 

the Judiciary, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To expand the investigative authorities of the United States 

Secret Service, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Combating Money 

5 Laundering in Cyber Crime Act of 2024’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7156 IH

1 SEC. 2. EXPANSION OF UNITED STATES SECRET SERVICES 

2 INVESTIGATIVE AUTHORITIES. 

3 Section 3056(b) of title 18, United States Code, is 

4 amended— 

5 (1) in paragraph (1), by striking ‘‘or 879’’ and 

6 inserting ‘‘879, or 1960’’; and 

7 (2) in paragraph (2), by striking ‘‘or’’ at the 

8 end; 

9 (3) in paragraph (3)— 

10 (A) by striking ‘‘federally insured’’; 

11 (B) by inserting ‘‘(as such term is defined 

12 in section 5312 of title 31)’’ after ‘‘institution’’; 

13 and 

14 (C) by striking the period at the end and 

15 inserting ‘‘; or’’; and 

16 (4) by adding at the end the following: 

17 ‘‘(4) section 5324 of title 31, except that the 

18 authority conferred by this paragraph shall be exer19 cised subject to the agreement of the Attorney Gen20 eral and the Secretary of Homeland Security and 

21 shall not affect the authority of any other Federal 

22 law enforcement agency with respect to those laws.’’. 

23 SEC. 3. FINCEN EXCHANGE. 

24 Section 310(d)(3)(A) of title 31, United States Code, 

25 is amended by striking ‘‘next 5 years’’ and inserting ‘‘next 

26 10 years’’. 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7156 IH

1 SEC. 4. INTERNATIONAL FINANCIAL INSTITUTIONS. 

2 Section 7125(b) of division F of the National Defense 

3 Authorization Act for Fiscal Year 2020 (22 U.S.C. 262p– 

4 13 note; Public Law 116–92) is amended by striking ‘‘5’’ 

5 and inserting ‘‘10’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
May 22, 2018

JUDGMENT

The Fourteenth Court of Appeals

IN THE INTEREST OF W.A.B., III, A CHILD

NO. 14-18-00181-CV 

________________________________

Today the Court heard its own motion to dismiss the appeal from the judgment 

signed by the court below on November 7, 2017. Having considered the motion and 

found it meritorious, we order the appeal DISMISSED.

We further order that all costs incurred by reason of this appeal be paid by 

appellant.

We further order this decision certified below for observance.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2010-N-0001]

# AGENCY:

 Food and Drug Administration, HHS.

# ACTION:

 Notice.

# SUMMARY:

                         The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Pulmonary-Allergy Drugs Advisory Committee. This meeting was announced in the                         **Federal Register**                         of February 2, 2010 (75 FR 5334). The amendment is being made to reflect a change in the                         *Name of Committee*                         portion of the document. There are no other changes.                    

# FOR FURTHER INFORMATION CONTACT:

                         Kristine T. Khuc, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail:                         *Kristine.Khuc@fda.hhs.gov*, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington DC area), code 3014512545. Please call the Information Line for up-to-date information on this meeting.                    

# SUPPLEMENTARY INFORMATION: 

                    In the                     **Federal Register**                     of February 2, 2010, FDA announced that a meeting of the Pulmonary-Allergy Drugs Advisory Committee would be held on March 10 and 11, 2010. On page 5334, in the second column, the                     *Name of Committee*                     portion of the document is changed to read as follows:                

*Name of Committees*: Joint Meeting of the Pulmonary-Allergy Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee.                

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

Dated: February 18, 2010.

Jill Hartzler Warner,

Acting Associate Commissioner for Special Medical Programs.

[FR Doc. 2010-3595 Filed 2-23-10; 8:45 am]

BILLING CODE 4160-01-S
EXHIBIT 23.1
                       CONSENT OF INDEPENDENT ACCOUNTANTS

We consent to the incorporation by reference in the registration statement on
Form S-8 (File No. 333-07031) of our report dated October 20, 1997, on our
audits of the consolidated financial statements and financial statement
schedule of Play By Play Toys & Novelties, Inc. and Subsidiaries as of
July 31, 1997 and 1996, and for each of the three years in the period
ended July 31, 1997, which report is included in this Annual Report on
Form 10-K.

COOPERS & LYBRAND L.L.P.

Austin, Texas
October 29, 1997
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                           9,098
<SECURITIES>                                    36,043
<RECEIVABLES>                                    3,449
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                49,673
<PP&E>                                           8,831
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  61,184
<CURRENT-LIABILITIES>                            7,165
<BONDS>                                         11,835
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            13
<OTHER-SE>                                      42,184
<TOTAL-LIABILITY-AND-EQUITY>                    61,184
<SALES>                                              0
<TOTAL-REVENUES>                                18,270
<CGS>                                                0
<TOTAL-COSTS>                                   42,129
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 767
<INCOME-PRETAX>                               (21,316)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (21,316)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (21,316)
<EPS-PRIMARY>                                   (1.75)<F1>
<EPS-DILUTED>                                   (1.75)
<FN>
<F1>FOR PURPOSES OF THIS EXHIBIT, PRIMARY MEANS BASIC.
</FN>
        

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 07-1999

WINDSOR COAL COMPANY,

Petitioner,

v.

EDGAR J. HUGGINS; DIRECTOR, OFFICE OF WORKERS’ COMPENSATION

PROGRAMS,

Respondents.

On Petition for Review of an Order of the Benefits Review Board.

(06-0710-BLA)

Submitted: May 30, 2008 Decided: June 25, 2008

Before NIEMEYER and DUNCAN, Circuit Judges, and WILKINS, Senior

Circuit Judge.

Petition denied by unpublished per curiam opinion.

William S. Mattingly, JACKSON KELLY PLLC, Morgantown, West

Virginia, for Petitioner. Stephen A. Sanders, APPALACHIAN CITIZENS

LAW CENTER, Whitesburg, Kentucky; Gregory F. Jacob, Solicitor of

Labor, Patricia M. Nece, Jeffrey S. Goldberg, UNITED STATES

DEPARTMENT OF LABOR, Washington, D.C., for Respondents.

Unpublished opinions are not binding precedent in this circuit.
- 2 -

PER CURIAM:

Windsor Coal Company seeks review of the Benefits Review

Board’s decision and order affirming the administrative law judge’s

award of black lung benefits on a claim filed by Edgar J. Huggins

pursuant to 30 U.S.C. §§ 901-945 (2000). Our review of the record

discloses that the Board’s decision is based upon substantial

evidence and is without reversible error. Accordingly, we deny the

petition for review for the reasons stated by the Board. Windsor

Coal Co. v. Huggins, No. 06-0710-BLA (B.R.B. Aug. 15, 2007). We

dispense with oral argument because the facts and legal contentions

are adequately presented in the materials before the court and

argument would not aid the decisional process.

PETITION DENIED
<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported) March 16, 1998.

                              THE LOEWEN GROUP INC.
             (Exact name of registrant as specified in its charter)



<TABLE>
<CAPTION>
<S>                                  <C>                         <C>
    British Columbia, Canada                 0-18429                      98-0121376
-------------------------------      ------------------------    ---------------------------------
(State or other jurisdiction of      (Commission File Number)    (IRS Employer Identification No.)
         incorporation)
</TABLE>


   4126 Norland Avenue, Burnaby, British Columbia              V5G 3S8
   ----------------------------------------------              -------
      (Address of principal executive offices)                (zip code)


     Registrant's telephone number, including area code      604-299-9321
                                                             ------------


                                       N/A
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)


                                                      Exhibit Index is on page 3
                                                                     Page 1 of 5


<PAGE>   2
ITEM 5.        OTHER EVENTS.

Pursuant to Form 8-K, General Instructions F, registrant hereby incorporates by
reference the press release attached hereto as Exhibit 99.


ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

        Exhibit No.   Description

        Exhibit 99    The Loewen Group Inc. Press Release dated March 16, 1998


                                   SIGNATURES

               Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Dated: March 17, 1998

                                            THE LOEWEN GROUP INC.



                                            By: /s/ PETER S. HYNDMAN
                                               --------------------------------
                                            Name:  Peter S. Hyndman
                                            Title:   Corporate Secretary


<PAGE>   3
                                  EXHIBIT INDEX


<TABLE>
<CAPTION>
                                                               Sequential
Number         Exhibit                                         Page Number
------         -------                                         -----------
<S>            <C>                                             <C>
99             The Loewen Group Inc.                                  4
               Press Release dated March 16, 1998
</TABLE>